chrysin and 1-anilino-8-naphthalenesulfonate

chrysin has been researched along with 1-anilino-8-naphthalenesulfonate* in 2 studies

Other Studies

2 other study(ies) available for chrysin and 1-anilino-8-naphthalenesulfonate

ArticleYear
Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis.
    International journal of biological macromolecules, 2020, Dec-15, Volume: 165, Issue:Pt B

    The post-translational modification of proteins by nonenzymatic glycation (NEG) and the accumulation of AGEs are the two underlying factors associated with the long-term pathogenesis in diabetes. Glyoxal (GO) is a reactive intermediate which has the ability to modify proteins and generate AGEs at a faster rate. Human serum albumin (HSA) being the most abundant serum protein has a higher chance to be modified by NEG. The key objective of the present study is to investigate the potency of chrysin and luteolin as antiglycating and antifibrillating agents in the GO-mediated glycation and fibril formation of HSA. AGEs formation were confirmed from the absorption and fluorescence spectral measurements. Both the flavonoids were able to quench the AGEs fluorescence intensity in vitro indicating the antiglycating nature of the molecules. The formation of fibrils in the GO-modified HSA was confirmed by the Thioflavin T (ThT) fluorescence assay and the flavonoids were found to exihibit the antifibrillation properties in vitro. Docking results suggested that both the flavonoids interact with various amino acid residues of subdomain IIA including glycation prone lysines and arginines via non-covalent forces and further stabilized the structure of HSA, which further explains their mechanisms of action as antiglycating and antifibrillating agents.

    Topics: Anilino Naphthalenesulfonates; Benzothiazoles; Binding Sites; Flavonoids; Fluorescamine; Glycation End Products, Advanced; Glyoxal; Humans; Hydrophobic and Hydrophilic Interactions; Luteolin; Molecular Docking Simulation; Protective Agents; Protein Aggregates; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tryptophan

2020
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
    Journal of medicinal chemistry, 2015, Sep-24, Volume: 58, Issue:18

    Death-associated protein kinase 1 (DAPK1) is a 160 kDa serine/threonine protein kinase that belongs to the Ca(2+)/calmodulin-dependent protein kinase subfamily. DAPK1 is a possible target for the treatment of acute ischemic stroke and endometrial adenocarcinomas. In the present study, we investigated the binding characteristics of 17 natural flavonoids to DAPK1 using a 1-anilinonaphthalene-8-sulfonic acid competitive binding assay and revealed that morin was the strongest binder among the selected compounds. The crystallographic analysis of DAPK1 and 7 selected flavonoid complexes revealed the structure-binding affinity relationship in atomic-level detail. It was suggested that the high affinity of morin could be accounted for by the ionic interaction between 2'-OH and K42 and that such an interaction would not take place with either cyclin-dependent protein kinases or PIM kinases because of their broader entrance regions. Thus, morin would be a more selective inhibitor of DAPK1 than either of these other types of kinases. In addition, we found that the binding of kaempferol to DAPK1 was associated with a chloride ion. The present study provides a better understanding of the molecular properties of the ATP site of DAPK1 and may be useful for the design of specific DAPK1 inhibitors.

    Topics: Adenosine Triphosphate; Allosteric Site; Anilino Naphthalenesulfonates; Binding, Competitive; Crystallography, X-Ray; Death-Associated Protein Kinases; Flavonoids; Kaempferols; Protein Binding; Protein Conformation; Structure-Activity Relationship

2015